Quinazolines useful as modulators of voltage gated ion channels

Details for Australian Patent Application No. 2006315675 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Wilson, Dean; Joshi, Pramod; Krenitsky, Paul; Fanning, Lev T. D.; Termin, Andreas; Sheth, Urvi

Agent Cullens

Pub. Number AU-B-2006315675

PCT Pub. Number WO2007/058989

Priority 60/737,330 14.11.05 US

Filing date 13 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 7 June 2012

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/505 (2006.01) - Pyrimidines

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/058989 Priority application(s): WO2007/058989

7 June 2012 Application Accepted

  Published as AU-B-2006315675

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315684-Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties

2006315668-MNTF differentiation and growth of stem cells